Bullboard - Stock Discussion Forum Alpha Cognition Inc ACOG

Healthcare Biotechnology

Alpha Cognition Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is engaged in developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI). The Company’s pipeline includes ALPHA-1062, ALPHA-0602, and ALPHA-0702 and ALPHA-0802 (GEMs). The Company’s ALPHA-1062... see more

Add To Watchlist

NDAQ:ACOG - Post Discussion

Alpha Cognition Inc > Alpha 1062 might be the next best-in-class ALZ drug

View:

Post by XeniaTechie on Nov 02, 2021 12:42pm

Alpha 1062 might be the next best-in-class ALZ drug

More coverage on $ACOG late-stage drug, Alpha-1062, this is promising as the next best-in-class Alzheimer's drug - they may be in position to file NDA in 2022 - once approved, insight on strong sales strategy and potential combination treatments. Tons of upside, target price of $5. https://www.cantechletter.com/2021/10/alpha-cognition-could-have-a-best-in-class-alzheimers-drug-ia-capital-says/

128